Method to determine the probability of contracting an hiv infection (Machine-translation by Google Translate, not legally binding)

The present invention is directed to methods for determining the probability that a subject becomes infected with hiv or becomes a patient without long-term progression after exposure to hiv based on the determination of the number of copies of the defa1a3 gene. Also, the present invention relates t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	RODRIGUEZ GARCIA, MARTA, CLIMENT VIDAL, NÚRIA, GALLART GALLART, TERESA
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention is directed to methods for determining the probability that a subject becomes infected with hiv or becomes a patient without long-term progression after exposure to hiv based on the determination of the number of copies of the defa1a3 gene. Also, the present invention relates to kits comprising reagents suitable for the determination of the number of copies of the defa1a3 gene. (Machine-translation by Google Translate, not legally binding) La presente invención está dirigida a métodos para determinar la probabilidad de que un sujeto se infecte por VIH o se convierta en un paciente sin progresión a largo plazo tras la exposición a VIH basados en la determinación del número de copias del gen DEFA1A3. Asimismo, la presente invención se relaciona con kits que comprenden reactivos adecuados para la determinación del número de copias del gen DEFA1A3.